NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/01/2024
Back to search
Official data from USPTO
NIPPON CHEMIPHAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NIPPON CHEMIPHAR
ST13
US500000097748253Class
1, 5, 10
Filing
97748253
Registration
7518883
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/01/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 10
Filing date
01/10/2023
Registration date
10/01/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/01/2024
Last transaction
10/01/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
GAGNER, NICHOLAS M
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Nippon Chemiphar Co., Ltd.
Representatives
Mary Margaret L. O'Donnell BLUE FILAMENT LAW PLLC
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for medical research; Diagnostic reagent kits consisting of chemical reagentscell culture reagentsbiochemical reagents for medical research
Class 5
Pharmaceutical preparations for Cardiovascular DisordersGenitourinary DisordersGynecological diseasesCancer and cancer supportive careEye DisordersNeurologic DisordersPsychiatric DisordersEndocrine and Metabolic DisordersAllergic DisordersGastrointestinal DisordersImmune Diseases and Autoimmune DiseasesRespiratory DiseasesMusculoskeletal and Connective Tissue DisordersInfectious DiseasesDermatologic DisordersHematological DisorderInflammatory DiseasesEarNoseDental and Throat DisordersHepatic and Biliary DisordersKidney DiseasesMedicines for improving sleepMedicines for controlling sickness from drinkingMedicines for controlling hangovers; Obstetric medicines being medical preparations for the treatment of endometriosis or adenomyosis; localtopicalgeneralinhalant anesthetic; Sedatives; Analgesic drugs; Alkalinizing agents being preparations for the lowering pH levels in patients; Anti-aging agents being pharmaceutical preparations for reducing the effects of aging in patients; reagent paper for medical purposes; pharmaceutical preparations for reducing painreducing inflammation; pharmaceutical preparations and substances with antipyretic properties anti-inflammatories and analgesic properties for the treatment of nociceptive painsthe treatment of neuropathic painsthe treatment of visceral painsthe treatment of rheumatoid arthritisthe treatment of low back painthe treatment of after surgerytraumatooth extraction; pharmaceutical preparations for the treatment of gout and hyperuricemia; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations and substances for the treatment of cancer; Hygiene agentmedical cleanser for skin and wounds; Eye patches and skin patches for medical purposespharmaceutical preparations for reducing painreducing inflammation; medicated ointments for treating dermatological conditions; Infusion drug for medical purposespharmaceutical preparations for reducing painreducing inflammation that need to be administered gradually intravenously; Diagnostic agents and reagents for medical use; diagnostic reagents for medical purposes; Medical diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; In vitro diagnostic reagent for medical use; In vitro diagnostic reagents kits consisting primarily of monoclonal antibodiesbuffersreagents for use in determining allergies; medical oiled paper; Drug delivery agents in the form of wafers for wrapping powdered pharmaceuticals for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages spray; Breast-nursing pads; cotton swabs for medical use; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Vitamin fortified beverages for babies for medical purposes; food for babies; dietary-supplements-for-animals other than drugs; Semen for artificial insemination; ferments for pharmaceutical purposes; Food supplementsantioxidant pills; dietary supplements for anti-aging immune system for humans; appetite suppressant pills; dietary fiber to aid digestion; pharmaceutical preparations for treating dry skin; Pharmaceutical preparations being medical application cream pharmaceuticals for treating skin conditions; pharmaceutical preparations for skin care; Nasal sprays for medical purposes
Class 10
Medical apparatus and instrumentsmedical devices for use in diagnosing allergies; Medical diagnostic apparatus and instruments for diagnostic for immunotherapy medical purposes; Medical diagnostic apparatus and instrumentsmedical devices for use in diagnosing allergies; apparatus for use in medical purpose for identifying allergens causing allergymedical devices for use in diagnosing allergies; medical diagnostic apparatus for testing and quantifying the amount of allergen-specific antibody; Genetic testing apparatus for medical purposes; medical measuring apparatusmedical apparatus for measuring skin hydration; Medical diagnostic apparatus for measuringtesting and analyzing specimens reacted with diagnostic reagents; medical diagnostic apparatusimmunoassay analyzer being medical diagnostic apparatus for testing for viruses; mobile medical apparatus for enzyme-linked immunosorbent assaymedical diagnostic apparatus for testing for blood proteinDNA for allergy screening; medical diagnostic apparatus for testing and measuring specific immunoglobulin E (IgE) antibodies; Sanitary masks for personal use; dental materials being dental implants
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2024
PUBO
PUBLISHED FOR OPPOSITION
07/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/30/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/23/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/23/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/23/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/23/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/22/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/22/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/22/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/22/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/23/2024
GNFR
FINAL REFUSAL E-MAILED
02/23/2024
CNFR
FINAL REFUSAL WRITTEN
02/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2023
GNRT
NON-FINAL ACTION E-MAILED
10/05/2023
CNRT
NON-FINAL ACTION WRITTEN
10/05/2023
DOCK
ASSIGNED TO EXAMINER
10/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/31/2023
NWAP
NEW APPLICATION ENTERED
01/13/2023
Continuous trademark protection
Get notified about every new filing that threatens NIPPON CHEMIPHAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.